©2023-2035 All Rights Reserved.
Online Journal of Veterinary Research. You may
not store these pages in any form except for your own personal use. All other
usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the
before mentioned must be gained in writing from the publisher. This
article is exclusively copyrighted in its entirety to onlinejournals@gmail.com
publications.. This article may be copied once but may
not be, reproduced or re-transmitted without the
express permission of the editors. Linking: To link to this page or any pages
linking to this page you must link directly to this page only here rather than
put up your own page.
OJVRTM
Online Journal of
Veterinary Research©
(Including Medical and Laboratory Research)
Established 1994
ISSN 1328-925X
Volume
28 (12): 827-852, 2024.
Repositioning
drugs to block proteolytic cleavage of Dengue virus
by inhibition of NS2B-NS3 polyprotein.
Hrithika Panday1, Saurabh Kumar Jha2,
Vivek Dhar Dwivedi3,4, Abhimanyu Kumar Jha1,5
1Department of
Biotechnology, School of Engineering & Technology, Sharda University,
Greater Noida, 2Department of Zoology, Kalindi
College University of Delhi, Delhi, 3Saveetha Medical College and
Hospitals, Center for Global Health Research, Saveetha
Institute of Medical and Technical Sciences, Saveetha
University, Chennai, 4Bioinformatics Research Division, Quanta
Calculus, Greater Noida, 5Department of Biotechnology, School of
Biosciences and Technology, Galgotias University,
Greater Noida, India
ABSTRACT
Panday H, Jha SK, Dwivedi VD, Jha AK., Repositioning
drugs to block proteolytic cleavage of Dengue virus by inhibition of NS2B-NS3
polyprotein. Onl
J Vet Res., 28
(12): 827-852, 2024. Dengue induces mild fever, hemorrhagic fever and
shock syndrome. NS2B-NS3 protease non-structural protein is involved in its replication.
We selected viral protease inhibitors by high throughput screening to select Stachyose, Amikacin, Kanamycin, and Proanthocyanidin
with -12.88 to -10.25 docking and -75.36
to -64.73kcal/mol binding free energy scores. In contrast, reference drugs were BEZ -4.6
and Policresulen -8.1 kcal/mol. Post-docking binding
scores for the selected compounds were -75.36,
-68.71, -62.29 and -64.73 kcal/mol and docking scores
of -7.0, -7.0, -7.1, and -8.6 kcal/mol, respectively.
Keywords-
Protease, Dengue, Repurposing, in-silico studies, FDA-approved drugs.
FULL-TEXT (SUBSCRIBE OR
PURCHASE TITLE)